Previous 10 | Next 10 |
BATON ROUGE, La., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the fourth quarter and year ended December 31, 2022, after the market closes on February 15, 2023. The...
Amedisys ( NASDAQ: AMED ) is up 5% in Wednesday afternoon trading after a Jefferies analyst said that returning CEO Paul Kusserow said the company will be more conservative with its guidance. Brian Tanquilut, who met with management recently, said that they realize that poor share...
BATON ROUGE, La., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Paul B. Kusserow, Chairman and Chief Executive Officer, will present at the 41 st Annual J.P. Morgan Healthca...
BATON ROUGE, La., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Foundry’s Computerworld recently named Amedisys, Inc. (NASDAQ: AMED) one of the nation’s leading home health, hospice, personal and high-acuity care companies, to their 2023 listing of the Best Places to Work in IT. This award...
LITTLE ROCK, Ark. and NASHVILLE, Tenn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its joint venture with the University of Arkansas for Medical Sciences (UAMS) to prov...
BATON ROUGE, La. and NASHVILLE, Tenn., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Amedisys is recognized as one of the most responsible companies in the nation, according to a report by Statista in the latest issue of Newsweek magazine. The recognition is based on key performance indicators derived from t...
BATON ROUGE, La., Dec. 02, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Paul B. Kusserow, Chairman and Chief Executive Officer and Scott Ginn, Chief Operating Officer, will present at t...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
BATON ROUGE, La., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, names Scott Ginn, Executive Vice President and Chief Financial Officer, its Acting Chief Operating Officer, effective immed...
Amedisys Confirms Full Year Guidance PR Newswire BATON ROUGE, La. , Nov. 17, 2022 /PRNewswire/ -- Today, the Board of Directors of Amedisys, Inc. (NASDAQ: AMED) announced a leadership change that President and Chief Executive Officer, Chris Gerard , will ...
News, Short Squeeze, Breakout and More Instantly...
BATON ROUGE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2024. Three-Month Periods Ended June 30, 2024 and 2023 Net service revenue increased $38.2 million to...
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Amedisys, Inc. (NASDAQ: AMED) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 3.74% on the day to $95.23. Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates thr...